GLOBAL CARDIAC PACEMAKER MARKET SIZE TO REACH USD 5 BILLION BY 2025, GROWING AT A CAGR OF 2% DURING THE FORECAST PERIOD.

Cardiac Pacemaker Market Size, Share, & Trends Analysis Report by Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis, Price Trends, Growth Potential, Competitive Analysis & Forecast, 2020-2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

263 Pages

icon-table

37 Tables

icon-chart

159 Charts

icon-region

6 Regions

icon-country

17 Countries

icon-company

12 Companies

icon-market

4 Market Segment

Cardiac Pacemaker Market Report Scope

Report Attribute Details
Market Size (Revenue) USD 5 BILLION (2025)
CAGR 2% (2020-2025)
Base Year 2019
Forecast Year 2020 - 2025
Market Segments Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Spain, Italy, Japan, China, India, South Korea, Australia, Brazil, Turkey, South Africa, Saudi Arabia, and Mexico

INDUSTRY INSIGHTS

The global cardiac pacemaker market size will reach USD 5 billion in 2025, growing at a CAGR of 2% during the forecast period. The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to arrhythmias, is expected to drive the market. Advancements in technology and engineering provide clinicians innovative ways to care for the aging population. Cardiac pacing, particularly, has witnessed a series of game-changing technologies in the past several years spurred by low-power electronics, high-density batteries, and innovative software designs. Such innovations are expected to drive the market.

Several government bodies and private organizations are involved in spreading awareness, information, and support for cardiovascular diseases, thereby affecting the market positively. The growing patient population with arrhythmias globally requires advanced and cost-effective treatment options with minimal side-effects and complications.

SNIPPETS

  • North America dominates the global market with over 30% revenue share, is expected to continue its dominant position during the forecast period
  • APAC is expected to grow at a faster rate, with a CAGR of over 4% during the period 2019­­–2025.
  • The MRI-conditional segment dominates the market, accounting for a share of over 50%.

CARDIAC PACEMAKER MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Products
  • Technology
  • Implantability
  • End-user
  • Geography                                                                

INSIGHTS BY PRODUCTS

The MRI-conditional segment accounted for over 50% of the cardiac pacemaker market share in 2019 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted require MRI scan during their lifespan. Many public organizations recommend implanting MRI-conditional ones to minimize the risk associated with MRI scans. Moreover, many public and private insurance companies offer reimbursement coverage for MRI scans for patients implanted with MRI-conditional devices, which increase affordability, thereby driving the market. Advancements in technology are influencing the market positively as traditional pacemakers are expected to malfunction, thus leading to complications. Hence, the increased complications related to conventional devices are likely to decrease the share of this equipment.

INSIGHTS BY TECHNOLOGY

Dual-chamber technology is accounted for the major market share. This type of technology is likely to continue its dominance due to the increasing number of patients with abnormal heart rhythm defects. These models are highly efficient in treating cardiac arrhythmias. Besides, the number of vendors offering such pacemakers is growing as many patients prefer this type.

Single chamber devices help to minimize the risk of infections related to MRI scans and are cost-effective. The demand for single chamber ones is increasing in developing and low-income countries.

Biventricular pacemakers/CRT-P is growing at a rapid pace as these devices minimize failure chances and efficiently treat rhythm disorders. All these advantages, along with increased public and private reimbursement coverage, are expected to boost the segment.

INSIGHTS BY IMPLANTABILITY    

Implantable CPs are growing at a rapid pace due to the increase in the geriatric population and the rise in arrhythmia and abnormal cardiovascular disorder prevalence rates. Advancements in technology, including the introduction of leadless, MRI-compatible, and other remote monitoring pacemaker devices, have fueled the demand for implantable ones, and the segment is expected to contribute significantly to the market. External CPs are expected to grow at a steady pace due to the increased number of patients opting for temporary cardiac devices.

INSIGHTS BY END-USER

Hospitals are the major end-user segment as a significant number of patients prefer to undergo surgeries in these settings due to better reimbursement policies. The growing aging population and the increasing prevalence of abnormal cardiovascular disorders are the other major factors contributing to the increase in implantation in hospitals.

Specialty cardiology centers (SCCs) are expected to grow at a significant rate owing to the availability of sophisticated infrastructure and the availability of advanced technology cardiac pacemakers these centers. Besides, SCCs have a high presence of highly skilled cardiovascular surgeons.

Ambulatory surgery centers (ASCs) are cost-effective clinics and offer high-quality care with minimal indirect treatment costs. These centers are equipped with advanced diagnostic and treatment equipment without complex administrative procedures. Such factors are likely to boost the prospects of the market.

INSIGHTS BY GEOGRAPHY

North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations. Europe is likely to grow at a healthy rate due to the accessibility of advanced healthcare services, especially for heart valve repair and replacement procedures. Also, the increasing incidence of abnormal heart rhythm, the rapid adoption of sophisticated cardiac pacemakers, and high healthcare expenditures are projected to increase the European market. Factors responsible for the growth of APAC are vendors' initiatives in spreading awareness and the rise in abnormal rhythm incidences due to change in living patterns, stress, and old age.

INSIGHTS BY VENDORS

The global cardiac pacemaker market share is highly competitive and characterized by the presence of vendors offering a wide range of advanced and innovative CPs. The market is witnessing rapid technological advancements and significantly affected by new product launches. All the companies that primarily derive revenue from cardiac pacemakers are expected to grow at a favorable rate. Multiple product launches and diversified product portfolio is likely to fuel their growth in recent years. Going forward, R&D activities are expected to become crucial for companies to maintain revenue growth in the coming years. Global players with their huge infrastructure, marketing strategies, distribution network, and R&D support are likely to expand their footprint in the market. Thus, small and emerging vendors find it increasingly difficult to compete with them in terms of innovation, brand image, technology, and price.

The cardiac pacemaker market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Product

  • MRI-conditional
  • Traditional

Technology

  • Dual-Chamber
  • Single Chamber
  • Biventricular Pacemakers/CRT-P

Implantability  

  • Implantable
  • External

End-user   

  • Hospitals
  • Specialty Cardiology Centers
  • ASCs

Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

Frequently Asked Questions

What is the Cardiac Pacemaker Market size and growth rate during the forecast period?

The cardiac pacemaker market size to reach USD 5 billion by 2025, growing at a CAGR of 2% during the forecast period.

What are the factors impacting the growth of the Cardiac Pacemaker Market share?

The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to arrhythmias, is expected to drive the market.

Who are the leading vendors in the cardiac pacemaker market, and what are their market shares?

The leading vendors in the market Medtronic, Boston Scientific, MicroPort Scientific, Abbott, and BIOTRONIK.

What are the factors aiding the growth of the North American cardiac pacemaker market during the forecast period?

North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations.

What is the growth of the MRI-conditional segment during the forecast period?

The MRI-conditional segment accounted for over 50% of the cardiac pacemaker market share in 2019 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted require MRI scan during their lifespan.

Download Free Sample

The cardiac pacemaker market is expected to grow at a CAGR of over 2% during the period 2019–2025.

The following factors are likely to contribute to the growth of the cardiac pacemaker market during the forecast period:

  • Increasing Demand for MRI-conditional Cardiac Pacemakers
  • Technological Advancements & Increasing Focus on Product Innovations
  • Increase in Target Patient Population with Cardiac Arrhythmias
  • Increasing Demand for Wireless & Automated Pacemakers Integrated with Remote Monitoring 

Base Year:                  2019

Forecast Year:           2019–2025

The study considers the present scenario of the cardiac pacemaker market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Medtronic
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Boston Scientific
  • MicroPort Scientific
  • Abbott
  • BIOTRONIK

Other Vendors

  • Galix Biomedical Instrumentation
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Lepu Medical
  • MEDICO
  • Osypka Medical
  • OSCOR
  • Shree Pacetronix
  • Vitatron

Market Segmentation by Product

  • MRI-conditional Pacemakers
  • Traditional Pacemakers

Market Segmentation by Technology

  • Dual Chamber Pacemakers
  • Single Chamber Pacemakers
  • Biventricular Pacemakers/CRT-P

Market Segmentation by Implantability  

  • Implantable Pacemakers
  • External Pacemakers

Market Segmentation by End-user   

  • Hospitals
  • Specialty Cardiology Centers
  • ASCs

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • Turkey
    • South Africa
    • Saudi Arabia

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Product

4.4.2 Market Segmentation by Technology

4.4.3 Market Segmentation by Implantability

4.4.4 Market Segmentation by End-user

4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Background

7.2 Permanent Pacemaker

7.2.1 Indications

7.3 Temporary Pacemaker

7.3.1 Indications

7.4 Cardiac Pacemaker Market Snapshot

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 High Demand for MRI-conditional Cardiac Pacemakers

8.1.2 Technological Advancements & Increasing Focus on Product Innovations

8.1.3 New Pacemaker Approvals/Launches

8.1.4 Increase in Target Patient Population with Cardiac Arrhythmias

8.2 Market Growth Restraints

8.2.1 Risks and Complications Associated with Pacemakers

8.2.2 Stringent Government Regulations & Product Recalls

8.2.3 High Cost of Pacemaker Implantation

8.3 Market Opportunities and Trends

8.3.1 Advent of Leadless Cardiac Pacemakers

8.3.2 High Growth Potential in Emerging Markets

8.3.3 Promising Investigational Pacemakers

8.3.4 Growing Demand for Automated Pacemakers Integrated with Remote Monitoring Platforms

9 Global Cardiac Pacemaker Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Cardiac Pacemaker Market by Products

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

10.3 MRI-conditional Cardiac Pacemakers

10.3.1 Market Overview

10.3.2 Market Size & Forecast

10.4 Traditional Cardiac Pacemakers

10.4.1 Market Overview

10.4.2 Market Size & Forecast

11 Cardiac Pacemaker Market by Technology

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.3 Dual Chamber Pacemakers

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Single Chamber Pacemakers

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 Biventricular Pacemakers/CRT-P

11.5.1 Market Overview

11.5.2 Market Size & Forecast

12 Cardiac Pacemaker Market by Implantability

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Implantable Pacemakers

12.3.1 Market Size & Forecast

12.4 External Pacemakers

12.4.1 Market Size & Forecast

13 Cardiac Pacemaker Market by End-User

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Hospitals

13.3.1 Market Size & Forecast

13.4 Specialty Cardiac Centers

13.4.1 Market Size & Forecast

13.5 ASCs

13.5.1 Market Size & Forecast

14 Cardiac Pacemaker Market by Geography

14.1 Market Snapshot & Growth Engine

14.2 Overview

15 North America

15.1 Market Overview

15.2 Market Size & Forecast

15.3 Key Countries

15.3.1 US: Market Size & Forecast

15.3.2 Canada: Market Size & Forecast

16 Europe

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 Germany: Market Size & Forecast

16.3.2 France: Market Size & Forecast

16.3.3 UK: Market Size & Forecast

16.3.4 Spain: Market Size & Forecast

16.3.5 Italy: Market Size & Forecast

17 APAC

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 Japan: Market Size & Forecast

17.3.2 China: Market Size & Forecast

17.3.3 India: Market Size & Forecast

17.3.4 Australia: Market Size & Forecast

18 Latin America

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Brazil: Market Size & Forecast

18.3.2 Mexico: Market Size & Forecast

19 Middle East & Africa

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Turkey: Market Size & Forecast

19.3.2 Saudi Arabia: Market Size & Forecast

19.3.3 South Africa: Market Size & Forecast

20 Competitive Landscape

20.1 Competition Overview

20.2 Market Share Analysis

20.2.1 Medtronic

20.2.2 Abbott

20.2.3 Boston Scientific

20.2.4 BIOTRONIK

20.2.5 MicroPort Scientific

21 Key Company Profiles

21.1 Medtronic

21.1.1 Business Overview

21.1.2 Major Product Offerings

21.1.3 Key Strengths

21.1.4 Key Strategies

21.1.5 Key Opportunities

21.2 Abbott

21.2.1 Business Overview

21.2.2 Major Product Offerings

21.2.3 Key Strengths

21.2.4 Key Strategies

21.2.5 Key Opportunities

21.3 Boston Scientific

21.3.1 Business Overview

21.3.2 Major Product Offerings

21.3.3 Key Strengths

21.3.4 Key Strategies

21.3.5 Key Opportunities

21.4 BIOTRONIK

21.4.1 Business Overview

21.4.2 Major Product Offerings

21.4.3 Key Strengths

21.4.4 Key Strategies

21.4.5 Key Opportunities

21.5 MicroPort Scientific

21.5.1 Business Overview

21.5.2 Major Product Offerings

21.5.3 Key Strengths

21.5.4 Key Strategies

21.5.5 Key Opportunities

22 Other Prominent Vendors

22.1 Galix Biomedical Instrumentation

22.1.1 Business Overview

22.1.2 Product Offerings

22.1.3 Key Strengths

22.1.4 Key Strategies

22.1.5 Key Opportunities

22.2 Lepu Medical

22.2.1 Business Overview

22.2.2 Product Offerings

22.2.3 Key Strengths

22.2.4 Key Strategies

22.2.5 Key Opportunities

22.3 MEDICO

22.3.1 Business Overview

22.3.2 Product Offerings

22.3.3 Key Strengths

22.3.4 Key Strategies

22.3.5 Key Opportunities

22.4 OSCOR

22.4.1 Business Overview

22.4.2 Product Offerings

22.4.3 Key Strengths

22.4.4 Key Strategies

22.4.5 Key Opportunities

22.5 Osypka Medical

22.5.1 Business Overview

22.5.2 Product Offerings

22.5.3 Key Strengths

22.5.4 Key Strategies

22.5.5 Key Opportunities

22.6 Shree Pacetronix

22.6.1 Business Overview

22.6.2 Product Offerings

22.6.3 Key Strengths

22.6.4 Key Strategies

22.6.5 Key Opportunities

22.7 Vitatron

22.7.1 Business Overview

22.7.2 Major Product Offerings

22.7.3 Key Strengths

22.7.4 Key Strategies

22.7.5 Key Opportunities

23 Report Summary

23.1 Key Takeaways

23.2 Strategic Recommendations

23.3 Quantitative Summary

23.3.1 By Product

23.3.2 By Technology

23.3.3 By Implantability

23.3.4 By End-user

23.3.5 By Geography

24 Appendix

24.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Cardiac Pacemaker Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               History of Cardiac Pacing from 1950 to 2016

Exhibit 4               Permanent Pacemaker Implantation Indications

Exhibit 5               Temporary Pacemaker Implantation Indications

Exhibit 6               Major Market Dynamics for Global Cardiac Pacemaker Market

Exhibit 7               Global Cardiac Pacemaker Share by Geography 2019 (%)

Exhibit 8               Global Cardiac Pacemaker Market by Products

Exhibit 9               Global Cardiac Pacemaker Market Share (%) in 2019

Exhibit 10             Impact of High Demand for MRI-conditional Pacemakers

Exhibit 11             Impact of Technological Advancements & Increasing Focus on Product Innovations

Exhibit 12             Advancements in Pacemaker Technology from 1950 to 2016

Exhibit 13             Evolution of Battery Usage in Cardiac Pacemaker from 1950 to 1970

Exhibit 14             Evolution of Pacemakers (Size & Weight) 1950–2013

Exhibit 15             Impact of New Pacemaker Approvals/Launches

Exhibit 16             Impact of Increase in the Target Patient Population with Cardiac arrhythmias

Exhibit 17             Age-Adjusted Prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)

Exhibit 18             Mortality Rate of Atrial Fibrillation Among Men in Developing & Developed Countries 1990-2015 (Per 100,000 population)

Exhibit 19             Mortality Rate of Atrial Fibrillation Among Women in Developing & Developed Countries 1990-2015 (Per 100,000 population)

Exhibit 20             Prevalence Rate of Atrial Fibrillation in Different Age Groups

Exhibit 21             Impact of Risks & Complications Associated with Pacemakers

Exhibit 22             Most Common Complications

Exhibit 23             Comparison of Major & Minor Complications Post Cardiac Pacemaker Implantation Up to 6 Months Follow-up

Exhibit 24             Major & Minor Complications Associated with Implantations

Exhibit 25             Major and Minor Complication Risks Percentage in Different Age Group Patients

Exhibit 26             Impact of Stringent Government Regulations Product Recalls

Exhibit 27             Devices Subjected to Class I and II Recalls as a Percentage of Estimated Worldwide Pacing System Sales 1980-1986

Exhibit 28             Impact of High Cost of Pacemaker Implantation

Exhibit 29             Percentage Breakdown of Various Cost Components in Pacemaker Implantation

Exhibit 30             Impact of Advent of Leadless Cardiac Pacemakers

Exhibit 31             Impact of High Growth Potential in Emerging Markets

Exhibit 32             Impact of Promising Investigational Pacemakers

Exhibit 33             Impact of Growing Demand for Automated Pacemakers Integrated with Remote Monitoring Platforms

Exhibit 34             Factors to be considered for Rhythmic Management (RM) Systems

Exhibit 35             Global Cardiac Pacemaker Market 2019−2025 ($ million)

Exhibit 36             Global Cardiac Pacemaker Market by Geography

Exhibit 37             Global Cardiac Pacemaker Market by Product

Exhibit 38             Global Cardiac Pacemaker Market by Technology

Exhibit 39             Global Cardiac Pacemaker Market by Implantability

Exhibit 40             Global Cardiac Pacemaker Market by End-user

Exhibit 41             Five Force Analysis 2019

Exhibit 42             Incremental Growth by Products 2019-2025

Exhibit 43             Market by Product

Exhibit 44             Market by Product: Incremental Growth

Exhibit 45             Market by Product: Absolute Growth

Exhibit 46             Market by Product 2019−2025 ($ million)

Exhibit 47             Market by Product 2019−2025 (%)

Exhibit 48             Global MRI-conditional Cardiac Pacemaker Market: Incremental $ Absolute Growth

Exhibit 49             Global Market by 2019−2025 ($ million)

Exhibit 50             Global Traditional Cardiac Pacemaker Market: Incremental $ Absolute Growth

Exhibit 51             Global Market 2019−2025 ($ million)

Exhibit 52             Incremental Growth by Technology 2019-2025

Exhibit 53             Market by Technology

Exhibit 54             Market by Technology: Incremental Growth

Exhibit 55             Market by Technology: Absolute Growth

Exhibit 56             Market by Technology 2019−2025 ($ million)

Exhibit 57             Market by Technology 2019−2025 (%)

Exhibit 58             Global Dual Chamber Pacemaker Market: Incremental $ Absolute Growth

Exhibit 59             Global Market 2019−2025 ($ million)

Exhibit 60             Global Single Chamber Pacemaker Market: Incremental $ Absolute Growth

Exhibit 61             Global Market 2019−2025 ($ million)

Exhibit 62             Global Biventricular Pacemaker Market: Incremental $ Absolute Growth

Exhibit 63             Global Market 2019−2025 ($ million)

Exhibit 64             Incremental Growth by Implantability 2019-2025

Exhibit 65             Market by Implantability

Exhibit 66             Market by Implantability: Incremental Growth

Exhibit 67             Market by Implantability: Absolute Growth

Exhibit 68             Market by Implantability 2019−2025 ($ million)

Exhibit 69             Market by Implantability 2019−2025 (%)

Exhibit 70             Global Implantable Pacemakers Market: Incremental & Absolute Growth

Exhibit 71             Global Market 2019−2025 ($ million)

Exhibit 72             Global External Pacemaker Market: Incremental & Absolute Growth

Exhibit 73             Global Market 2019−2025 ($ million)

Exhibit 74             Incremental Growth by End-user 2019-2025

Exhibit 75             Market by End-user

Exhibit 76             Market by End-user: Incremental Growth

Exhibit 77             Market by End-user: Absolute Growth

Exhibit 78             Market by End-user 2019−2025 ($ million)

Exhibit 79             Market by End-user 2019−2025 (%)

Exhibit 80             Market by Hospitals: Incremental & Absolute Growth

Exhibit 81             Market by Hospitals 2019−2025 ($ million)

Exhibit 82             Market by Speciality Cardiac Centers: Incremental & Absolute Growth

Exhibit 83             Market by Speciality Cardiac Centers 2019−2025 ($ million)

Exhibit 84             Market by ASCs: Incremental & Absolute Growth

Exhibit 85             Market by ASCs 2019−2025 ($ million)

Exhibit 86             Incremental Growth by Geography 2019-2025

Exhibit 87             Global Cardiac Pacemaker Market by Geography

Exhibit 88             Global Cardiac Pacemaker Market: Absolute Growth & Market Share

Exhibit 89             Market by Geography 2019: Key Countries ($ million)

Exhibit 90             Market by Geography: Incremental Growth

Exhibit 91             Market by Geography: Absolute Growth

Exhibit 92             Market by Geography 2019−2025 ($ million)

Exhibit 93             Market by Geography 2019−2025 (%)

Exhibit 94             North America Cardiac Pacemaker Market 2019

Exhibit 95             North America Market: Absolute & Incremental Growth

Exhibit 96             Market in North America 2019–2025 ($ million)

Exhibit 97             Incremental Growth in North America 2019-2025

Exhibit 98             Market in US 2019–2025 ($ million)

Exhibit 99             Market in Canada 2019–2025 ($ million)

Exhibit 100          Country-wise Pacemakers Implantations per Million Inhabitants 2009 vs. 2013

Exhibit 101          Europe Cardiac Pacemaker Market 2019

Exhibit 102          Europe Market: Incremental & Absolute Growth

Exhibit 103          Market in Europe 2019–2025 ($ million)

Exhibit 104          Incremental Growth in Europe 2019-2025

Exhibit 105          Number of Pacemakers Implanting Centers in EU 2013

Exhibit 106          Market in Germany 2019–2025 ($ million)

Exhibit 107          Market in France 2019–2025 ($ million)

Exhibit 108          Pacemakers Implantation Centers in UK 2012 & 2013

Exhibit 109          Market in UK 2019–2025 ($ million)

Exhibit 110          Distribution of Insurance Modality in Spain (%)

Exhibit 111          Market in Spain 2019–2025 ($ million)

Exhibit 112          Market in Italy 2019–2025 ($ million)

Exhibit 113          APAC Cardiac Pacemaker Market in 2019

Exhibit 114          APAC Market: Incremental & Absolute Growth

Exhibit 115          Payment by Governments for Cardiac Pacemakers Implantation in Various APAC Countries (%)

Exhibit 116          Market in APAC 2019–2025 ($ million)

Exhibit 117          Incremental Growth in APAC 2019-2025

Exhibit 118          Market in Japan 2019–2025 ($ million)

Exhibit 119          Market in China 2019–2025 ($ million)

Exhibit 120          Cost Comparison of Cardiac Pacemakers in India & US

Exhibit 121          Market in India 2019–2025 ($ million)

Exhibit 122          Market in Australia 2019–2025 ($ million)

Exhibit 123          Latin America Cardiac Pacemaker Market 2019

Exhibit 124          Latin America Market: Incremental & Absolute Growth

Exhibit 125          Market in Latin America 2019–2025 ($ million)

Exhibit 126          Incremental Growth in Latin America 2019-2025

Exhibit 127          Number of Implantations Performed in Various Developing Countries Per Million Population

Exhibit 128          Reimbursement Cost in Brazil ($US)

Exhibit 129          Market in Brazil 2019–2025 ($ million)

Exhibit 130          Market in Mexico 2019–2025 ($ million)

Exhibit 131          MEA Cardiac Pacemaker Market in 2019

Exhibit 132          MEA Market: Incremental & Absolute Growth

Exhibit 133          Sub-Saharan Africa Increasing Cardiac Pacing (%) 2004-2015

Exhibit 134          Market in MEA 2019–2025 ($ million)

Exhibit 135          Incremental Growth in MEA 2019-2025

Exhibit 136          Market in Turkey 2019–2025 ($ million)

Exhibit 137          Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 138          Market in South Africa 2019–2025 ($ million)

Exhibit 139          Global Cardiac Pacemaker Market: Vendors Shares 2019

Exhibit 140          Medtronic Sales Revenue 2017-2019 ($ million)

Exhibit 141          Medtronic Sales Revenue by Business Segment 2018-2019 ($ million)

Exhibit 142          Medtronic Revenue Share by Business Segments 2019 (%)

Exhibit 143          Medtronic Revenue Share by Region (%) 2019

Exhibit 144          Medtronic R&D Expenditure 2017-2019 ($ million)

Exhibit 145          Abbott Sales Revenue 2016-2018 ($ billion)

Exhibit 146          Abbott Sales Revenue by Business Segment 2017 & 2018 ($ billion)

Exhibit 147          Abbott R&D Expenditure 2017 & 2018 ($ million)

Exhibit 148          Abbott Revenue Share by Business Segments 2018 (%)

Exhibit 149          Abbott Revenue Share by Countries 2018 (%)

Exhibit 150          Boston Scientific Sales Revenue 2016-2018 ($million)

Exhibit 151          Boston Scientific Sales Revenue by Business Segments 2017 & 2018 ($ million)

Exhibit 152          Boston Scientific Revenue Share Business Segments 2018 (%)

Exhibit 153          Boston Scientific Revenue Share by Region 2018 (%)

Exhibit 154          Boston Scientific R&D Expenditure 2016-2018 ($ million)

Exhibit 155          MicroPort Scientific Sales Revenue 2016-2018 ($ million)

Exhibit 156          MicroPort Scientific Sales Revenue by Business Segment 2017 & 2018 ($ million)

Exhibit 157          MicroPort Scientific Revenue Share by Business Segments 2018 (%)

Exhibit 158          MicroPort Scientific Revenue Share by Region 2018 (%)

Exhibit 159          MicroPort Scientific R&D Expenditure 2017 & 2018 ($ million)

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2014−2019

Table 3                  Major Modifications Introduced in MRI-conditional Cardiac Pacemakers

Table 4                  List of MRI-Compatible Pacemakers Offered by Various Vendors

Table 5                  Life Span of Few Popular Cardiac Pacemakers

Table 6                  List of New Product Launch from 2014-2019

Table 7                  Incidence Rate of Various Complications Post Cardiac Pacemaker Implantation

Table 8                  Comparison of Micra and Nanostim Leadless Cardiac Pacemakers

Table 9                  Absolute Growth Comparison of Pacemakers Between Developed and Emerging Economies (%)

Table 10               Promising Investigational Pacemaker Devices

Table 11               Vendors Offering MRI-conditional Pacemakers

Table 12               Major Vendors Offering Implantable Pacemaker

Table 13               Major Vendors Offering External pacemaker

Table 14               Provincial Reimbursement Policy in China

Table 15               Global Cardiac Pacemakers Vendor Ranking 2019

Table 16               Medtronic: Product Offerings

Table 17               Abbott: Product Offerings

Table 18               Boston Scientific: Product Offerings

Table 19               BIOTRONIK: Product Offerings

Table 20               MicroPort Scientific: Product Offerings

Table 21               Galix Biomedical Instrumentation: Key Product Offerings

Table 22               Lepu Medical: Key Product Offerings

Table 23               MEDICO: Key Product Offerings

Table 24               OSCOR: Key Product Offerings

Table 25               Osypka Medical: Key Product Offerings

Table 26               Shree Pacetronix: Key Product Offerings

Table 27               Vitatron: Product Offerings

Table 28               Market by Product ($ million)

Table 29               Market by Product (%)

Table 30               Market by Technology ($ million)

Table 31               Market by Technology (%)

Table 32               Market by Implantability ($ million)

Table 33               Market by Implantability (%)

Table 34               Market by End-user ($ million)

Table 35               Market by End-user (%)

Table 36               Market by Geography ($ million)

Table 37               Market by Geography (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date